CN Patent

CN119909077B — 一种抗菌药物及其应用

Assigned to Changsha City No1 Hospital · Expires 2026-04-24 · 0y expired

What this patent protects

本发明公开了一种抗菌药物及其应用，抗菌药物为6‑苄基‑3‑(4‑氯苯基)‑5‑甲基吡唑并[1,5‑a]嘧啶‑7‑醇，在维塔斯‑M实验室中编号为STK848198。本发明的抗菌药物，通过破坏质子动力势和靶向ATP酶FtsH蛋白发挥抗金黄色葡萄球菌的作用，具有耐药性概率低，细胞毒性和心脏毒性小的特点，可应用于制备治疗细菌感染的药物。

USPTO Abstract

本发明公开了一种抗菌药物及其应用，抗菌药物为6‑苄基‑3‑(4‑氯苯基)‑5‑甲基吡唑并[1,5‑a]嘧啶‑7‑醇，在维塔斯‑M实验室中编号为STK848198。本发明的抗菌药物，通过破坏质子动力势和靶向ATP酶FtsH蛋白发挥抗金黄色葡萄球菌的作用，具有耐药性概率低，细胞毒性和心脏毒性小的特点，可应用于制备治疗细菌感染的药物。

Drugs covered by this patent

acoramidis-hydrochloride (ACORAMIDIS HYDROCHLORIDE)

Patent Metadata

Patent number: CN119909077B
Jurisdiction: CN
Classification: —
Expires: 2026-04-24
Drug substance claim: No
Drug product claim: No
Assignee: Changsha City No1 Hospital
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.